recombinant PIV5 based vaccine (University of Iowa/University of Georgia)

N/A

Report date: 2025/01/26 17:44:10

Base Information

Drug Namerecombinant PIV5 based vaccine (University of Iowa/University of Georgia)

Drug Alias Namerecombinant parainfluenza virus vector vaccine (University of Iowa/University of Georgia)

ClassificationVaccines > Development/production technology > Inactivated vaccine > Subunit vaccineVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Recombinant vector vaccine

Mechanisms of ActionCoronavirus spike glycoprotein modulators

TargetsCoronavirus spike glycoprotein

Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesThe University Of Iowa

China Registration ClassN/A

Develop Information

Active CompaniesThe University Of Iowa University Of Georgia

Inactive CompaniesN/A

Active IndicationsCoronavirus Disease 2019 (COVID-19)

Inactive IndicationsN/A

Other Information

ATC CodeN/A